Home › NDC Lookup › RxCUI directory › RxCUI 314266

Tacrolimus 0.001 MG/MG Topical Ointment — RxCUI 314266

RxNorm drug concept · Semantic clinical drug
RxCUI 314266 Semantic clinical drug · SCD ● Current RxNorm concept 9 FDA products 27 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI314266
Official nameTacrolimus 0.001 MG/MG Topical Ointment
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known astacrolimus 0.1 % Topical Ointment; tacrolimus (as tacrolimus monohydrate) 0.001 MG/MG Topical Ointment
FDA products mapped9
Package NDCs mapped27
Reported Medicaid activity (SDUD)408,485 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Tacrolimus: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • That's a great question, and it's one of the most important things to understand. Your body's immune system doesn't just stop trying to attack the new organ once you leave the hosp...
  • Why do I have to take tacrolimus even when I feel completely fine?
  • It actually does matter — but the key is being consistent, not choosing one over the other. Food can change how much tacrolimus your body absorbs, so if you always take it the same...
  • Does it matter if I take tacrolimus with food or on an empty stomach?
📖 Read our full Tacrolimus guide →

🕸️ Concept Web — How Tacrolimus 0.001 MG/MG Topical Ointment Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Tacrolimus 0.001 MG/MG Topical Ointment RxCUI 314266

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Tacrolimus 42316
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Tacrolimus Topical Ointment 379082
    • Tacrolimus Topical Product 1164204
    • Topical Ointment 316985
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Tacrolimus 0.001 MG/MG 331549

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Tacrolimus 0.001 MG/MG SCDC · 331549
  • Tacrolimus Topical Ointment SCDF · 379082
  • Tacrolimus Topical Product SCDG · 1164204

📦 FDA Products & Package NDCs

9 products · 27 package NDCs
27 package NDCs map to RxCUI 314266 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00168-0416-30 1 TUBE in 1 CARTON (0168-0416-30) / 30 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
00168-0416-60 1 TUBE in 1 CARTON (0168-0416-60) / 60 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
00168-0416-99 1 TUBE in 1 CARTON (0168-0416-99) / 100 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
00168-0417-30 1 TUBE in 1 CARTON (0168-0417-30) / 30 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
00168-0417-60 1 TUBE in 1 CARTON (0168-0417-60) / 60 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
00168-0417-99 1 TUBE in 1 CARTON (0168-0417-99) / 100 g in 1 TUBE Tacrolimus E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC 2014-09-09
16729-0421-01 1 TUBE in 1 CARTON (16729-421-01) / 100 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-06-05
16729-0421-10 1 TUBE in 1 CARTON (16729-421-10) / 30 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-05-31
16729-0421-12 1 TUBE in 1 CARTON (16729-421-12) / 60 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-05-31
16729-0422-01 1 TUBE in 1 CARTON (16729-422-01) / 100 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-06-05
16729-0422-10 1 TUBE in 1 CARTON (16729-422-10) / 30 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-05-31
16729-0422-12 1 TUBE in 1 CARTON (16729-422-12) / 60 g in 1 TUBE Tacrolimus Accord Healthcare Inc. 2019-05-31
21922-0011-05 1 TUBE in 1 CARTON (21922-011-05) / 30 g in 1 TUBE Tacrolimus Encube Ethicals, Inc. 2023-10-13
21922-0011-07 1 TUBE in 1 CARTON (21922-011-07) / 60 g in 1 TUBE Tacrolimus Encube Ethicals, Inc. 2023-10-13
21922-0011-09 1 TUBE in 1 CARTON (21922-011-09) / 100 g in 1 TUBE Tacrolimus Encube Ethicals, Inc. 2023-10-13
45802-0390-00 1 TUBE in 1 CARTON (45802-390-00) / 30 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
45802-0390-01 1 TUBE in 1 CARTON (45802-390-01) / 60 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
45802-0390-02 1 TUBE in 1 CARTON (45802-390-02) / 100 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
45802-0700-00 1 TUBE in 1 CARTON (45802-700-00) / 30 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
45802-0700-01 1 TUBE in 1 CARTON (45802-700-01) / 60 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
45802-0700-02 1 TUBE in 1 CARTON (45802-700-02) / 100 g in 1 TUBE Tacrolimus Padagis Israel Pharmaceuticals Ltd 2014-11-20
68462-0534-35 1 TUBE in 1 CARTON (68462-534-35) / 30 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2018-04-16
68462-0534-65 1 TUBE in 1 CARTON (68462-534-65) / 60 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2018-04-16
68462-0534-94 1 TUBE in 1 CARTON (68462-534-94) / 100 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2018-04-16
68462-0881-35 1 TUBE in 1 CARTON (68462-881-35) / 30 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2023-08-16
68462-0881-65 1 TUBE in 1 CARTON (68462-881-65) / 60 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2023-08-16
68462-0881-94 1 TUBE in 1 CARTON (68462-881-94) / 100 g in 1 TUBE Tacrolimus Glenmark Pharmaceuticals Inc., USA 2023-08-16
Observed labelers: Accord Healthcare Inc. (6) · E. Fougera & Co. a division of Fougera Pharmaceuticals, LLC (6) · Glenmark Pharmaceuticals Inc., USA (6) · Padagis Israel Pharmaceuticals Ltd (6) · Encube Ethicals, Inc. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.